Search Count: 19
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.61 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant E166A With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: GOL, V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant E166V With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: GOL, V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant L50F E166V With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: DMS, V2M, CL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease M49I Mutant In Complex With Pf00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2024-05-01 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
 |
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Main Protease G15S Mutant In Complex With Pf00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Main Protease K90R Mutant In Complex With Pf00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.68 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Main Protease P132H Mutant In Complex With Pf00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Main Protease V186F Mutant In Complex With Pf00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.66 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Main Protease Y54C Mutant In Complex With Pf00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Main Protease S46F Mutant In Complex With Pf00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.64 Å Release Date: 2024-04-17 Classification: VIRAL PROTEIN/INHIBITOR Ligands: V2M |
 |
Crystal Structure Of Sars Cov-2 Mpro Mutant L141R With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN Ligands: DMS, V2M, NA |
 |
Crystal Structure Of Sars Cov-2 Mpro Mutant N142P With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: V2M |
 |
Crystal Structure Of Sars Cov-2 Mpro With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2023-03-29 Classification: VIRAL PROTEIN/HYDROLASE/INHIBITOR Ligands: GOL, V2M, DMS |
 |
Crystal Structure Of Porcine Deltacoronavirus (Hku-15) Mpro With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Porcine deltacoronavirus
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2023-03-29 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: V2M, GOL, DMS |
 |
Covalent Complex Of Sars-Cov Main Protease With N-[(2S)-1-({(2S,3S)-3,4-Dihydroxy-1-[(3S)-2-Oxopyrrolidin-3-Yl]Butan-2-Yl}Amino)-4-Methyl-1-Oxopentan-2-Yl]-4-Methoxy-1H-Indole-2-Carboxamide
Organism: Human sars coronavirus
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2020-07-08 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Covalent Complex Of Sars-Cov-2 Main Protease With N-[(2S)-1-({(2S,3S)-3,4-Dihydroxy-1-[(3S)-2-Oxopyrrolidin-3-Yl]Butan-2-Yl}Amino)-4-Methyl-1-Oxopentan-2-Yl]-4-Methoxy-1H-Indole-2-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.41 Å Release Date: 2020-07-08 Classification: VIRAL PROTEIN Ligands: V2M, EDO |